Inhibition of spinal protein kinase Calpha expression by an antisense oligonucleotide attenuates morphine

X-Y Hua1, A Moore, S Malkmus

  • 1Anesthesia Research Laboratory, Department of Anesthesiology, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92103-0818, USA. xyhua@ucsd.edu

Neuroscience
|July 19, 2002
PubMed

Insights

Targeting protein kinase C-alpha (PKCα) with antisense oligonucleotides reversed morphine tolerance in rats. This suggests PKCα activation in the spinal cord is crucial for developing opiate tolerance.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Protein kinase C (PKC) isoforms are linked to morphine tolerance.
  • Understanding the specific role of PKC isoforms in spinal morphine tolerance is essential.

Purpose of the Study:

  • To investigate the effect of intrathecal protein kinase C-alpha (PKCα) antisense oligonucleotide on spinal morphine tolerance.
  • To determine if reducing spinal PKCα expression can reverse established morphine tolerance.

Main Methods:

  • Rats received continuous intrathecal morphine infusion to induce tolerance.
  • Antisense or missense oligonucleotides targeting PKCα mRNA were administered intrathecally.
  • Paw withdrawal thresholds and analgesia from a probe morphine dose were measured.
  • Spinal PKCα mRNA and protein expression were analyzed using RT-qPCR and Western blots.

Main Results:

  • Intrathecal PKCα antisense treatment maintained morphine analgesia and reversed tolerance.
  • PKCα antisense significantly reduced spinal PKCα mRNA and protein expression.
  • PKCα missense treatment had no effect on morphine tolerance or PKCα expression.
  • PKCα inhibition attenuated spinal PKC-mediated phosphorylation.

Conclusions:

  • Selective reduction of spinal PKCα expression reverses morphine-induced tolerance.
  • PKCα activation in the spinal cord plays a specific role in opiate tolerance development.
  • Targeting spinal PKCα may offer a strategy to manage opioid tolerance.